Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
about
Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver CirrhosisHepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesBiomarkers for the early diagnosis of hepatocellular carcinomaInsights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic interventionLiver Diseases and Long Non-Coding RNAs: New Insight and PerspectiveTherapeutic potential of the translation inhibitor silvestrol in hepatocellular cancerEstablishment and characterization of 7 novel hepatocellular carcinoma cell lines from patient-derived tumor xenograftsApplying NGS Data to Find Evolutionary Network Biomarkers from the Early and Late Stages of Hepatocellular Carcinoma.Functions of endothelin-1 in apoptosis and migration in hepatocellular carcinoma.Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UKBiomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapyLow SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma.α-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy.Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis.Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomyRMP predicts survival and adjuvant TACE response in hepatocellular carcinoma.Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.Developmental Stage-Specific Hepatocytes Induce Maturation of HepG2 Cells by Rebuilding the Regulatory CircuitLiver cancer oncogenomics: opportunities and dilemmas for clinical applications.Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.Significance of Serum Cytokeratin-18 in Prediction of Hepatocellular Carcinoma in Chronic Hepatitis C Infected Egyptian Patients.Linking MLL and the HGF-MET signaling pathway in liver cancer.Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cellsDecrease of fibulin-3 in hepatocellular carcinoma indicates poor prognosis.Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients.Increased liver carcinogenesis and enrichment of stem cell properties in livers of Dickkopf 2 (Dkk2) deleted mice.miR-612 suppresses stem cell-like property of hepatocellular carcinoma cells by modulating Sp1/Nanog signaling.Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits.Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133.Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.Next-generation sequencing: application in liver cancer-past, present and future?DNA microarray-based gene expression profiling of estrogenic chemicals.Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma.Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24.Human genetic variation and the risk of hepatocellular carcinoma development.A novel prognostic index-neutrophil times γ-glutamyl transpeptidase to lymphocyte ratio (NγLR) predicts outcome for patients with hepatocellular carcinomaPeritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular CarcinomaLong non-coding RNA XIST promotes cell growth by regulating miR-139-5p/PDK1/AKT axis in hepatocellular carcinoma.Gene of the month: HGF.Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA).
P2860
Q26740317-13033C34-6395-4329-BD82-052F9BDAF409Q26772317-E56B5F3B-35BA-4F04-A835-F99047A52967Q26784418-EB2DC8AF-4618-49DA-9C8D-1A45E84DB05FQ28080281-A0D0A17B-36BD-45A1-9EB7-E5AB38AFBF6EQ28084106-4B375FDD-6B72-44D8-9DB2-8F86F3688F1EQ28533823-57B85631-08F5-4DFA-86B5-4C0D0C7D45C0Q28538581-7D6E20DF-5C4A-4F59-B715-9473A96C7377Q30993390-9D611222-431B-4DE0-ACCD-8D749A4D9E1EQ33744900-4337ACDA-17A1-4C63-A4E6-849DDE26AB31Q33795154-2EA5AD72-4A51-41DA-89F7-74D2DA413EA6Q34256150-0C837561-1641-4E7F-A87C-F3AFC15D2AC4Q34525541-6D120440-A683-4D78-A9F3-5E06F034165DQ34611324-B84F9C2F-B75D-45E4-B123-946BC2849736Q34880476-551CDA9F-1FB3-438A-B812-10EDA5D0D7C1Q34956865-570B9936-396C-41FB-B772-DDF08C6DFA45Q35550266-628D7F36-27BB-4B8F-BDD5-70F402D63526Q35745018-104C2593-C3EB-488B-8879-78E2FD7A6C37Q35855687-3C901146-59E6-4CE3-8C05-021AA2BF6DCFQ35913384-BE2697D8-ABDC-4B02-B2DA-5AD6C795F8BAQ36772115-2F9FB999-07D3-4D0D-BB50-E1E37783DD55Q36929039-4FF1E16C-B9A9-4055-8DA0-AB32D3BC286FQ36967008-DB95548B-8376-4EBC-86E6-FC791371B0F9Q36975026-E47DB34C-9B33-4FD5-A5E7-E2D12FFB591CQ37064102-4FFF7C94-509C-4FB4-A7C0-FA7661DBC046Q37138421-915BF981-E20F-4728-B219-001EC75D7408Q37301702-C72E95AA-80F7-4D49-ADF3-C6D2ECF0B241Q37330910-2C5C3112-EA82-49B0-84D2-7CCC416E679DQ37619600-C7FC8D3A-8236-4F87-90CB-CD5C9088E9ADQ37734673-2255F9B6-641C-40E0-BD63-48F82906B222Q38046452-EECC9B98-0180-443F-A2B0-E646D99FA4BAQ38113220-83C3E50E-7284-44AE-9EDF-890DD92628E2Q38176554-FE633E8F-6AC1-453F-ADF5-E254970F75A9Q38238010-C6D06DBE-1D4A-440A-B98A-9BE3D3CE027FQ38311444-CFE8760D-8E1A-44A0-855A-741C2462799DQ38552272-F28F6412-7A89-4B15-99C0-1782FD993AC8Q38611103-B9EBEBBA-C774-4788-8FF0-3E511FEE8ED8Q38675948-4ADA6FB9-4B4D-45C3-94F3-A7D5B3C968DAQ38715197-AABCDF48-FC58-4A5A-8BB2-7351ED00E038Q38806819-655DBC0D-5E25-4D88-8C86-2A11E5B1895AQ38947665-A826502D-F384-499A-9E4D-27D2ABC928D8
P2860
Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular diagnosis and therap ...... eld for advanced technologies.
@en
Molecular diagnosis and therapy of hepatocellular carcinoma
@nl
type
label
Molecular diagnosis and therap ...... eld for advanced technologies.
@en
Molecular diagnosis and therapy of hepatocellular carcinoma
@nl
prefLabel
Molecular diagnosis and therap ...... eld for advanced technologies.
@en
Molecular diagnosis and therapy of hepatocellular carcinoma
@nl
P1476
Molecular diagnosis and therap ...... ield for advanced technologies
@en
P2093
Andreas Teufel
Peter R Galle
P304
P356
10.1016/J.JHEP.2011.07.007
P577
2011-07-23T00:00:00Z